These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36983252)

  • 1. The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review.
    Miyamoto Y; Honda A; Yokose S; Nagata M; Miyamoto J
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats.
    Masuda T; Ohara K; Vallon V; Nagata D
    Am J Physiol Renal Physiol; 2022 Sep; 323(3):F361-F369. PubMed ID: 35900341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the G-protein and α2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial.
    Yang YY; Lin HC; Lee WP; Chu CJ; Lin MW; Lee FY; Hou MC; Jap JS; Lee SD
    Gut; 2010 Nov; 59(11):1545-53. PubMed ID: 20833658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
    Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic Action of Sodium-Glucose Cotransporter 2 Inhibitors and Its Importance in the Management of Heart Failure.
    Kimura G
    Circ J; 2016 Oct; 80(11):2277-2281. PubMed ID: 27599528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan.
    Osawa L; Nakanishi H; Kurosaki M; Kirino S; Inada K; Yamashita K; Hayakawa Y; Sekiguchi S; Wang W; Okada M; Higuchi M; Komiyama Y; Takaura K; Takada H; Kaneko S; Maeyashiki C; Tamaki N; Yasui Y; Tsuchiya K; Itakura J; Takahashi Y; Enomoto N; Izumi N
    Dig Dis; 2022; 40(4):479-488. PubMed ID: 34348262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sodium-glucose cotransporter-2 inhibitors and aldosterone antagonists, in addition to renin-angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
    Yang S; Zhao L; Mi Y; He W
    Diabetes Obes Metab; 2022 Nov; 24(11):2159-2168. PubMed ID: 35712807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of refractory ascites.
    Singhal S; Baikati KK; Jabbour II; Anand S
    Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S; Bologna E; Terracina D; Angelico M
    Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
    Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G
    Front Endocrinol (Lausanne); 2021; 12():738848. PubMed ID: 34745006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
    Reed JW
    Vasc Health Risk Manag; 2016; 12():393-405. PubMed ID: 27822054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia in cirrhosis: pathophysiology and management.
    John S; Thuluvath PJ
    World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ascites].
    Jeong SW
    Korean J Gastroenterol; 2018 Aug; 72(2):49-55. PubMed ID: 30145856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and Cardiovascular Effects of sodium-glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial.
    Mordi NA; Mordi IR; Singh JS; Baig F; Choy AM; McCrimmon RJ; Struthers AD; Lang CC
    BMJ Open; 2017 Oct; 7(10):e018097. PubMed ID: 29042392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors.
    Mareev YV; Mareev VY
    Kardiologiia; 2021 Jul; 61(6):4-10. PubMed ID: 34311683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na
    Kravtsova O; Bohovyk R; Levchenko V; Palygin O; Klemens CA; Rieg T; Staruschenko A
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F692-F707. PubMed ID: 35466690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.